Afuco™ Anti-Human ERBB3 ADCC Therapeutic Antibody (LJM716), ADCC Enhanced
Anti-ERBB3 ADCC Enhanced Antibody (LJM716) is an ADCC enhanced antibody produced by our Afuco™ platform. LJM716 is an anti-HER3 antibody that inhibits both HER2 and NRG driven tumor growth by trapping HER3 in the inactive conformation.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-232CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ERBB3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |